Related Experiment Video
Updated: May 6, 2026

Training a Sophisticated Microsurgical Technique: Interposition of External Jugular Vein Graft in the Common Carotid Artery in Rats
Published on: November 11, 2012
Postoperative outcomes in patients with anemia undergoing carotid revascularization
Ahmed Abdelkarim1, Sabrina L Straus1, Marjan Moghaddam1
1Division of Vascular & Endovascular Surgery, Department of Surgery, Center for Learning and Excellence in Vascular and Endovascular Surgery, UC San Diego, San Diego, CA.
Insights
Transcarotid artery revascularization (TCAR) shows improved outcomes for anemic patients undergoing carotid procedures. TCAR is linked to lower mortality and major adverse cardiac events compared to transfemoral carotid artery stenting (TFCAS) and carotid endarterectomy (CEA).
Area of Science:
- Vascular Surgery
- Cardiovascular Interventions
- Anemia Management
Background:
- Preoperative anemia is a known risk factor for adverse outcomes following major vascular surgery.
- Optimal carotid revascularization strategies for anemic patients remain under-researched.
- This study addresses the comparative effectiveness of different carotid revascularization methods in anemic patients.
Purpose of the Study:
- To compare 30-day mortality and in-hospital major adverse cardiac events (MACE) after carotid endarterectomy (CEA), transfemoral carotid artery stenting (TFCAS), and transcarotid artery revascularization (TCAR) in patients with anemia.
- To identify the safest and most effective carotid revascularization technique for anemic individuals.
Main Methods:
- Retrospective analysis of the Vascular Quality Initiative database (2016-2023).
- Inclusion of patients with anemia, defined as hemoglobin <13 g/dL (men) or <12 g/dL (women).
- Multivariate logistic regression models were employed to analyze primary outcomes: 30-day mortality and in-hospital MACE.
Main Results:
- The study analyzed 40,383 CEA, 9,159 TFCAS, and 18,555 TCAR cases in anemic patients.
- TCAR demonstrated significantly lower 30-day mortality (aOR 0.45) and MACE (aOR 0.58) compared to TFCAS.
- TCAR showed a trend towards lower 30-day mortality (aOR 0.80) versus CEA, with similar MACE rates.
- TFCAS was associated with increased 30-day mortality (aOR 2.0) and MACE (aOR 1.7) compared to CEA.
Conclusions:
- Transfemoral carotid artery stenting (TFCAS) is associated with higher risks of mortality and MACE in anemic patients compared to CEA and TCAR.
- Transcarotid artery revascularization (TCAR) offers a lower risk of 30-day mortality compared to CEA in this population.
- TCAR emerges as a potentially optimal minimally invasive option for carotid revascularization in patients with anemia.
Background:
Preoperative anemia is associated with worse postoperative morbidity and mortality after major vascular procedures. Limited research has examined the optimal method of carotid revascularization in patients with anemia. Therefore, we aim to compare the postoperative outcomes after carotid endarterectomy (CEA), transfemoral carotid artery stenting (TFCAS), and transcarotid artery revascularization (TCAR) among patients with anemia.
Study Design:
This is a retrospective review of patients with anemia undergoing CEA, TFCAS, and TCAR in the Vascular Quality Initiative database between 2016 and 2023. We defined anemia as a preoperative hemoglobin level of <13 g/dL in men and <12 g/dL in women. The primary outcomes were 30-day mortality and in-hospital major adverse cardiac events (MACE). Logistic regression models were used for multivariate analyses.
Results:
Our study included 40,383 CEA (59.3%), 9159 TFCAS (13.5%), and 18,555 TCAR (27.3%) cases in patients with anemia. TCAR patients were older and had more medical comorbidities than CEA and TFCAS patients. TCAR was associated with a decreased 30-day mortality (adjusted odds ratio [aOR], 0.45; 95% confidence interval [CI], 0.37-0.59; P < .001), in-hospital MACE (aOR, 0.58; 95% CI, 0.46-0.75; P < .001) compared with TFCAS. Additionally, TCAR was associated with a 20% decrease in the risk of 30-day mortality (aOR, 0.80; 95% CI, 0.65-0.98; P = .03) and a similar risk of in-hospital MACE (aOR, 0.86; 95% CI, 0.77-1.01; P = .07) compared with CEA. Furthermore, TFCAS was associated with an increased risk of 30-day mortality (aOR, 2; 95% CI, 1.5-2.68; P < .001) and in-hospital MACE (aOR, 1.7; 95% CI, 1.4-2; P < .001) compared with CEA.
Conclusions:
In this multi-institutional national retrospective analysis of a prospectively collected database, TFCAS was associated with a high risk of 30-day mortality and in-hospital MACE compared with CEA and TCAR in patients with anemia. TCAR was associated with a lower risk of 30-day mortality compared with CEA. These findings suggest TCAR as the optimal minimally invasive procedure for carotid revascularization in patients with anemia.
More Related Videos
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm IV: Nursing Management

